Aptorum Group Ltd (NASDAQ:APM)’s stock price fell 3.1% on Monday . The company traded as low as $17.00 and last traded at $17.00, 1,200 shares changed hands during mid-day trading. A decline of 66% from the average session volume of 3,496 shares. The stock had previously closed at $17.55.
The business has a 50 day moving average price of $22.06.
Aptorum Group Company Profile (NASDAQ:APM)
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas.
Featured Article: Consumer behavior in bull markets
Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.